fbpx

Latest news

A New Approach to Therapeutic Drug Monitoring of Tobramycin in Cystic Fibrosis
24 Sep 2018 | Uncategorised

A New Approach to Therapeutic Drug Monitoring of Tobramycin in Cystic Fibrosis

EXECUTIVE SUMMARY INTRODUCTION Intravenous (IV) tobramycin, an aminoglycoside antibiotic, is a standard treatment for Pseudomonas infection in patients with cystic fibrosis (CF). However, drug exposure must be maintained within a narrow therapeutic range. If the dose is too high, there is an increased risk of adverse events, such as nephrotoxicity and...

Read more
Vancomycin Loading Dose: The Pharmacokinetics to Consider
4 Sep 2018 | Blog

Vancomycin Loading Dose: The Pharmacokinetics to Consider

A vancomycin loading dose – a large dose given once at the onset of therapy to rapidly achieve a therapeutic drug concentration – is required due to the pharmacokinetics of vancomycin to ensure that vancomycin levels are not subtherapeutic at the beginning of treatment. Vancomycin is a broad spectrum glycopeptide antibiotic...

Read more
DoseMe to Present at IATDMCT Congress 2018
31 Aug 2018 | Company Announcement

DoseMe to Present at IATDMCT Congress 2018

DoseMe Chief Scientific Officer, Dr Robert McLeay, will present at this years International Association of Therapeutic Drug Monitoring and Clinical Toxicology Congress  (IATDMCT) from 16-17 September in Brisbane, Australia. Dr McLeay will present his work on "Barriers overcome: A case study of deploying model-informed precision dosing across five...

Read more
University Hospitals of Leicester NHS Trust Select DoseMeRx to Optimize ICU Vancomycin Dosing
20 Aug 2018 | Company Announcement

University Hospitals of Leicester NHS Trust Select DoseMeRx to Optimize ICU Vancomycin Dosing

DoseMe today announced that DoseMeRx - the leading clinical decision support tool for precision dose calculations -  has been selected for assessment by the University Hospitals of Leicester NHS Trust to optimize the dosing of vancomycin used in intensive care patients to treat MRSA blood stream infections. The project will evaluate...

Read more
New vancomycin obese & hemodialysis models released!Check it out →
+

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.